ICD-10-CM Billable Code

M05.412

Rheumatoid myopathy with rheumatoid arthritis of left shoulder

Clinical Classification Guidelines

Medical Intelligence & Overview

Rheumatoid myopathy with rheumatoid arthritis of the left shoulder is a condition characterized by inflammation and muscle weakness associated with rheumatoid arthritis (RA), primarily affecting the muscles around the left shoulder. This condition involves both joint inflammation and muscle involvement, leading to discomfort, limited mobility, and muscle weakness. It is often part of systemic rheumatoid arthritis, which is a chronic autoimmune disorder that primarily targets joints but can also impact muscles and other tissues.

Causes & Symptoms

Clinical Causes: Autoimmune process: The primary cause of RA and related myopathy is an autoimmune reaction where the immune system mistakenly attacks the body's own tissues. Genetic factors: Certain genetic predispositions can increase the likelihood of developing RA and associated muscle complications. Environmental exposures: Smoking, infections, and other environmental factors may contribute to the development and progression of rheumatoid arthritis. Muscle inflammation: The immune response may also target muscle tissues, leading to inflammation and weakness specific to affected areas like the shoulder. Chronic joint inflammation: Ongoing inflammation in the shoulder joint can extend to surrounding muscles, resulting in rheumatoid myopathy.

Key Symptoms: Persistent shoulder pain and stiffness Muscle weakness around the left shoulder Swelling and tenderness in the shoulder joint Reduced range of motion in the shoulder Muscle fatigue, especially after activity Warmth and redness over the affected shoulder General signs of rheumatoid arthritis such as fever, fatigue, and malaise

Diagnostic & Treatment

Diagnosis Path: Medical history review, focusing on symptoms and duration Physical examination to assess joint and muscle strength, swelling, and tenderness Blood tests: rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) to evaluate inflammation Imaging studies: X-rays, MRI, or ultrasound of the shoulder to identify joint damage and muscle inflammation Muscle biopsy: In some cases, a biopsy may be performed to confirm muscle inflammation and distinguish it from other muscle disorders

Treatment Protocols: Disease-modifying antirheumatic drugs (DMARDs): Medications such as methotrexate and sulfasalazine help slow disease progression Biologic agents: Targeted therapies like TNF inhibitors may be prescribed for active disease Nonsteroidal anti-inflammatory drugs (NSAIDs): To manage pain and inflammation Corticosteroids: Short-term use of prednisone to control severe inflammation Physical therapy: Exercises and therapies designed to maintain joint mobility and strengthen surrounding muscles Occupational therapy: Strategies to assist with daily activities and improve quality of life Lifestyle modifications: Including regular low-impact exercises, smoking cessation, and adequate rest

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M05.412 a billable ICD-10 code?
Yes, M05.412 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M05.412?
Clinical documentation must specify the nature of Rheumatoid myopathy with rheumatoid arthritis of left shoulder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference